HealthPolitics
STAT+: White House pulls nomination of Heidi Overton to lead FDA
Publication: STAT
Author: Margaret Manto and Daniel Payne
Source published: 18/11/2026, 00:44:05 UTC
Briefing created: 18/11/2026, 01:11:14 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 18/11/2026, 00:51:24 UTC.
Briefings
The Trump administration withdrew Heidi Overton's nomination to lead the FDA after Republican opposition on the Senate health panel failed to provide sufficient support. This decision occurred following reports that Overton, a former Trump White House aide, lacked necessary backing from her party's health committee, which was scheduled to vote on her nomination Wednesday. The withdrawal was first reported by Axios on Tuesday evening.
Key points
- The Trump administration withdrew Heidi Overton's nomination to lead the FDA due to lack of Republican support on the Senate health panel.
- Overton, a preventive care doctor and former Trump White House aide, was nominated by the administration but faced opposition from her party's health committee.
Context
The decision marks a significant shift in the administration's approach to regulatory leadership, reflecting broader political tensions within the Republican party regarding healthcare policy and executive appointments.
Limitations
Evidence is limited to a single source report from Axios; no confirmation of the Senate vote outcome or final confirmation status is provided.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 18/11/2026, 01:11:14 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiconacds2o7hifz4aynj7nk4a5d32cum5uvk5l7zgkup6nil5nrqm